Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANGION BIOMEDICA CORP.

(ANGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about ANGION BIOMEDICA CORP.
01/05ANGION BIOMEDICA : Current Corporate Presentation
PU
01/05ANGION BIOMEDICA : Results of Operations and Financial Condition - Form 8-K
PU
01/04ANGION BIOMEDICA CORP. : Results of Operations and Financial Condition, Costs Associated w..
AQ
01/04Angion Provides Corporate Update and Announces Participation in Upcoming Investor Confe..
AQ
01/04Angion Biomedica Corp. Provides ANG-3070 Program Update
CI
2021Health Care Stocks Holding Onto Midday Gains
MT
2021Health Care Stocks Flat To Higher Premarket Thursday
MT
2021Angion Biomedica Jumps in Pre-Market Trading After CEO Jay Venkatesan Acquires More Tha..
MT
2021Oppenheimer Adjusts Angion Biomedica PT to $8 From $15, Maintains Outperform Rating
MT
2021Health Care Stocks Mixed Premarket Friday
MT
2021Angion Biomedica, Vifor Pharma's Mid-Stage Trial of Acute Kidney Injury Drug Fails to M..
MT
2021Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in..
BU
2021Angion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in ..
GL
2021Angion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in ..
GL
2021INSIDER SELL : Angion Biomedica
MT
2021Angion Provides Corporate Update and Reports Third Quarter 2021 Financial Results - For..
PU
2021ANGION BIOMEDICA CORP. Management's Discussion and Analysis of Financial Condition and..
AQ
2021Angion Biomedica Corp. Reports Earnings Results for the Third Quarter and Nine Months E..
CI
2021Earnings Flash (ANGN) ANGION BIOMEDICA Reports Q3 Loss $-0.53
MT
2021Earnings Flash (ANGN) ANGION BIOMEDICA Reports Q3 Revenue $1.5M
MT
2021Angion Provides Corporate Update and Reports Third Quarter 2021 Financial Results
AQ
2021HC Wainwright Adjusts Angion Biomedica's Price Target to $50 From $100, Reiterates Buy ..
MT
2021Angion Presents Multiple Posters on ANG-3070 at Kidney Week 2021, Including Preclinical..
AQ
2021Angion to Participate in Upcoming Investment Conference
AQ
2021Top Midday Decliners
MT
2021Stifel Adjusts Price Target on Angion Biomedica to $15 from $40, Keeps Buy Rating
MT
2021Oppenheimer Adjusts Angion Biomedica PT to $15 From $38, Maintains Outperform Rating
MT
2021Wall Street Treads Water Pre-Bell, Consolidating After Dow, S&P Hit Fresh Record Highs
MT
2021Top Premarket Decliners
MT
2021Angion Biomedica Late-Stage Trial of Kidney Transplant Drug Fails to Meet Primary Endpo..
MT
2021Angion Biomedica Says Late-Stage Trial of Kidney Transplant Drug Fails to Meet Primary ..
MT
2021ANGION BIOMEDICA CORP. : Results of Operations and Financial Condition (form 8-K)
AQ
2021Angion and Vifor Pharma Report Topline Results from Phase 3 Trial of ANG-3777 in Kidney..
AQ
2021ANGION BIOMEDICA : to Present Multiple Posters at Kidney Week 2021
AQ
2021ANGION BIOMEDICA : Hosting Research & Development Day on ANG-3070 for the Treatment of Lun..
AQ
2021ANGION BIOMEDICA : to Participate in Upcoming September Investment Conferences
AQ
2021ANGION BIOMEDICA : Termination of Material Definitive Agreement (Form 8-K)
PU
2021ANGION BIOMEDICA CORP. : Termination of a Material Definitive Agreement (form 8-K)
AQ
2021Sinovant Sciences HK Limited Intends to Terminate Its Exclusive License Agreement with ..
CI
2021ANGION BIOMEDICA : Provides Corporate Update and Reports Second Quarter 2021 Financial Res..
PU
2021ANGION BIOMEDICA : Earnings Flash (ANGN) ANGION BIOMEDICA Reports Q2 Revenue $540,000
MT
2021ANGION BIOMEDICA : Earnings Flash (ANGN) ANGION BIOMEDICA Reports Q2 Loss $-0.58
MT
2021ANGION BIOMEDICA : Management's Discussion and Analysis of Financial Condition and Results..
AQ
2021ANGION BIOMEDICA : Provides Corporate Update and Reports Second Quarter 2021 Financial Res..
AQ
2021Angion Biomedica Corp. Announces Unaudited Consolidated Earnings Results for the Three ..
CI
2021Certain Restricted Stock Units of Angion Biomedica Corp. are subject to a Lock-Up Agree..
CI
2021Certain Warrants of Angion Biomedica Corp. are subject to a Lock-Up Agreement Ending on..
CI
2021Certain Common Stock of Angion Biomedica Corp. are subject to a Lock-Up Agreement Endin..
CI
2021Certain Options of Angion Biomedica Corp. are subject to a Lock-Up Agreement Ending on ..
CI
2021ANGION BIOMEDICA : Reports Positive Results in Early-Stage Study of Fibrotic Diseases Drug..
MT
2021ANGION BIOMEDICA : Reports Positive Results from Phase 1 Healthy Volunteer Study for ANG-3..
AQ
2021Angion Biomedica Corp Reports Positive Results from Phase 1 Healthy Volunteer Study for..
CI
2021ANGION BIOMEDICA : Phase 2 Trial of ANG-3777 in Severe COVID-19-Related Pneumonia Fails to..
MT
2021ANGION BIOMEDICA CORP. : Other Events (form 8-K)
AQ
2021ANGION BIOMEDICA : Announces Results from the Phase 2 ALI-201 Study in Patients with COVID..
AQ
2021Angion Biomedica Corp. Announces Results from the Phase 2 ALI-201 Study in Patients wit..
CI
2021ANGION BIOMEDICA CORP.(NASDAQGS : ANGN) dropped from Russell 3000E Value Index
CI
2021ANGION BIOMEDICA CORP.(NASDAQGS : ANGN) dropped from Russell Microcap Value Index
CI
2021ANGION BIOMEDICA CORP.(NASDAQGS : ANGN) dropped from Russell 3000 Value Index
CI
2021ANGION BIOMEDICA CORP.(NASDAQGS : ANGN) dropped from Russell 2000 Value Index
CI
2021ANGION BIOMEDICA CORP.(NASDAQGS : ANGN) dropped from Russell 2500 Value Index
CI
2021ANGION BIOMEDICA CORP.(NASDAQGS : ANGN) dropped from Russell Small Cap Comp Value Index
CI
2021ANGION BIOMEDICA : Q1 Loss Widens, Revenue Declines
MT
2021ANGION BIOMEDICA : Earnings Flash (ANGN) ANGION BIOMEDICA Reports Q1 Loss $-1.56
MT
2021ANGION BIOMEDICA : Earnings Flash (ANGN) ANGION BIOMEDICA Posts Q1 Revenue $371,000
MT
2021ANGION BIOMEDICA : Provides Corporate Update and Reports First Quarter 2021 Financial Resu..
AQ
2021ANGION BIOMEDICA : Management's Discussion and Analysis of Financial Condition and Results..
AQ
2021Angion Biomedica Corp. Announces Unaudited Consolidated Earnings Results for the Three ..
CI
2021Angion and Vifor Pharma Announce Completion of Enrollment in Phase 2 Study of ANG-3777 ..
GL
2021ANGION BIOMEDICA : Posts Wider Q4 Loss, Revenue Drops
MT
2021ANGION BIOMEDICA : Management's Discussion and Analysis of Financial Condition and Results..
AQ
2021ANGION BIOMEDICA : Earnings Flash (ANGN) ANGION BIOMEDICA Reports Q4 Loss $-1.90
MT
2021ANGION BIOMEDICA : Earnings Flash (ANGN) ANGION BIOMEDICA Reports Q4 Revenue $459,000
MT
2021Angion Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financia..
GL
2021Angion Biomedica Corp. Announces Unaudited Consolidated Earnings Results for the Fourth..
CI
1  2Next
Upcoming event on ANGION BIOMEDICA CORP.